G Grosu

498 total citations
19 papers, 342 citations indexed

About

G Grosu is a scholar working on Organic Chemistry, Molecular Biology and Social Psychology. According to data from OpenAlex, G Grosu has authored 19 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Organic Chemistry, 7 papers in Molecular Biology and 3 papers in Social Psychology. Recurrent topics in G Grosu's work include Synthesis and Reactions of Organic Compounds (4 papers), Synthesis and biological activity (3 papers) and Neuroendocrine regulation and behavior (3 papers). G Grosu is often cited by papers focused on Synthesis and Reactions of Organic Compounds (4 papers), Synthesis and biological activity (3 papers) and Neuroendocrine regulation and behavior (3 papers). G Grosu collaborates with scholars based in United States, Romania and Canada. G Grosu's co-authors include Ionel I. Mangalagiu, John W. Ellingboe, Peter S. Chan, Joseph Coupet, Guixian Jin, John F. DiJoseph, Arie Zask, Jerauld S. Skotnicki, Amy Sung and J. Donald Albright and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and European Journal of Medicinal Chemistry.

In The Last Decade

G Grosu

19 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G Grosu United States 10 222 119 45 33 19 19 342
Richard J. Franklin United Kingdom 11 165 0.7× 182 1.5× 44 1.0× 11 0.3× 11 0.6× 12 339
Argyrios G. Arvanitis United States 9 200 0.9× 110 0.9× 33 0.7× 4 0.1× 18 0.9× 15 390
Harunobu Mukaiyama Japan 11 170 0.8× 112 0.9× 27 0.6× 5 0.2× 20 1.1× 18 339
Koji Tomimoto Japan 11 217 1.0× 147 1.2× 34 0.8× 14 0.4× 24 1.3× 19 379
Helen J. Mason United Kingdom 11 173 0.8× 120 1.0× 27 0.6× 10 0.3× 37 1.9× 18 286
Jay R. Wiggins United States 10 134 0.6× 101 0.8× 34 0.8× 29 0.9× 11 0.6× 21 330
David J. O’Neill United States 8 157 0.7× 140 1.2× 31 0.7× 14 0.4× 15 0.8× 11 333
Clara I. Villamil United States 11 194 0.9× 143 1.2× 78 1.7× 62 1.9× 17 0.9× 16 369
Mary Beth Young United States 9 111 0.5× 130 1.1× 24 0.5× 14 0.4× 15 0.8× 15 368
Robert T. Shuman United States 9 124 0.6× 202 1.7× 62 1.4× 39 1.2× 7 0.4× 13 379

Countries citing papers authored by G Grosu

Since Specialization
Citations

This map shows the geographic impact of G Grosu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Grosu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Grosu more than expected).

Fields of papers citing papers by G Grosu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Grosu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Grosu. The network helps show where G Grosu may publish in the future.

Co-authorship network of co-authors of G Grosu

This figure shows the co-authorship network connecting the top 25 collaborators of G Grosu. A scholar is included among the top collaborators of G Grosu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Grosu. G Grosu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Tsou, Hwei‐Ru, Gary H. Birnberg, G Grosu, et al.. (2010). Discovery and optimization of 2-(4-substituted-pyrrolo[2,3-b]pyridin-3-yl)methylene-4-hydroxybenzofuran-3(2H)-ones as potent and selective ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR). Bioorganic & Medicinal Chemistry Letters. 20(7). 2321–2325. 34 indexed citations
2.
Nittoli, Thomas, Russell G. Dushin, M. Brawner Floyd, et al.. (2009). The identification of 8,9-dimethoxy-5-(2-aminoalkoxy-pyridin-3-yl)-benzo[c][2,7]naphthyridin-4-ylamines as potent inhibitors of 3-phosphoinositide-dependent kinase-1 (PDK-1). European Journal of Medicinal Chemistry. 45(4). 1379–1386. 21 indexed citations
3.
Nikitenko, Antonia A., Michael W. Winkley, Kenneth A. M. Kremer, et al.. (2006). Selective Hydrolysis of Ethyl 5,6-Dihydro-4H-pyrrolo[1,2-b]pyrazole-2-carboxylate and Ethyl 5,6-Dihydro-4H-pyrrolo[1,2-b]pyrazole-3-carboxylate as a Key Step in the Large-Scale Synthesis of Bicyclic Heteroaryl Carboxyaldehydes. Organic Process Research & Development. 10(4). 712–716. 14 indexed citations
4.
Venkatesan, Aranapakam M., et al.. (2005). (4-Substituted-phenyl)-(5H-10,11-dihydro-pyrrolo [2,1-c][1,4] benzodiazepin-10-yl)-methanone derivatives as vasopressin receptor modulators. Bioorganic & Medicinal Chemistry Letters. 15(22). 5003–5006. 9 indexed citations
5.
6.
Sum, Fuk‐Wah, John P. Dusza, Efren Delos Santos, et al.. (2003). Structure–activity study of novel tricyclic benzazepine arginine vasopressin antagonists. Bioorganic & Medicinal Chemistry Letters. 13(13). 2195–2198. 34 indexed citations
7.
Grosu, G, Baihua Hu, John W. Ellingboe, et al.. (2003). Synthesis and Structure−Activity Relationship of α-Sulfonylhydroxamic Acids as Novel, Orally Active Matrix Metalloproteinase Inhibitors for the Treatment of Osteoarthritis. Journal of Medicinal Chemistry. 46(12). 2361–2375. 47 indexed citations
8.
Danac, Ramona, et al.. (2002). [In vitro antimicrobial activity of new 1,10-phenantroline derivatives].. PubMed. 60(5). 348–51. 8 indexed citations
9.
Grosu, G, et al.. (2001). [New pyrrolo-pyrimidine derivatives with antifungal or antibacterial properties in vitro].. PubMed. 59(2). 139–40. 40 indexed citations
10.
Grosu, G, et al.. (2000). Hydrazones and formazans with possible biological activity.. PubMed. 101(3-4). 178–82. 2 indexed citations
11.
Albright, J. Donald, et al.. (1999). 4,10-dihydro-5H-thieno[3,2-c][1]benzazepine derivatives and 9,10-dihydro-4H-thieno[2,3-c][1]benzazepine derivatives as orally active arginine vasopressin receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 9(13). 1733–1736. 9 indexed citations
12.
Gilbert, A., Aradhana M. Venkatesan, Gerardo D. Francisco, et al.. (1999). Prodrugs of CL316243: a selective β3-adrenergic receptor agonist for treating obesity and diabetes. Bioorganic & Medicinal Chemistry Letters. 9(14). 1921–1926. 19 indexed citations
13.
14.
Grosu, G, et al.. (1999). [New derivatives of 1-methyl-phthalazine with antimicrobial and fungistatic action].. PubMed. 57(5). 415–6. 8 indexed citations
15.
Mangalagiu, Ionel I., et al.. (1998). [Antimicrobial activity of some derivatives of pyrimidine].. PubMed. 56(4). 181–3. 6 indexed citations
16.
Mangalagiu, Ionel I., et al.. (1997). [Antimicrobial activity of new pyridazine derivatives].. PubMed. 55(2). 69–72. 34 indexed citations
17.
Grosu, G, et al.. (1994). [The antibacterial action of new hydrazide derivatives].. PubMed. 97(1). 433–7. 2 indexed citations
18.
Miller, Bernard, et al.. (1993). Thermal fragmentation reactions of dihydroaromatic molecules. The Journal of Organic Chemistry. 58(8). 2320–2323. 3 indexed citations
19.
Grosu, G, et al.. (1980). [Antimicrobial activity of several indigenous peloid extracts in solutions for external use].. PubMed. 83(2). 307–10. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard J. Franklin Breakdown of academic impact, for papers by Argyrios G. Arvanitis Breakdown of academic impact, for papers by Harunobu Mukaiyama Breakdown of academic impact, for papers by Koji Tomimoto Breakdown of academic impact, for papers by Helen J. Mason Breakdown of academic impact, for papers by Jay R. Wiggins Breakdown of academic impact, for papers by David J. O’Neill Breakdown of academic impact, for papers by Clara I. Villamil Breakdown of academic impact, for papers by Mary Beth Young Breakdown of academic impact, for papers by Robert T. Shuman
Rankless by CCL
2026